Hackers are reportedly offering stolen drug formulations and artificial intelligence models from Novo for a ransom of $25 million. The group claims to have obtained sensitive information that includes proprietary recipes for medications.
Despite the demand, Novo has indicated that it will not engage in negotiations with the cybercriminals. The situation has raised concerns regarding the security of pharmaceutical data and the potential implications for the industry.
The hackers have threatened to release the stolen materials if their demands are not met, heightening fears among stakeholders in the healthcare sector. As the deadline approaches, Novo is likely to enhance its cybersecurity measures in response to the breach.